AVITA MEDICAL INC (RCEL) Stock Earnings & Estimates
NASDAQ:RCEL - US05380C1027 - Common Stock
4.56 USD
-0.09 (-1.94%)
4.66 USD
+0.1 (+2.19%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 34.42M 17.76% | 50.143M 45.68% | 64.251M 28.14% | 82.392M 28.23% | 111.43M 35.24% | 167.42M 50.25% | 283.93M 69.59% | 352.93M 24.30% | 403.04M 14.20% | 477.35M 18.44% | 581.25M 21.77% | |
| EBITDA YoY % growth | -26.56M -3.79% | -41.715M -57.06% | -54.873M -31.54% | -23.432M 57.30% | -10.47M 55.32% | 3.314M 131.65% | 37.077M 1,018.80% | 43.512M 17.36% | 49.743M 14.32% | 55.462M 11.50% | 61.08M 10.13% | |
| EBIT YoY % growth | -27.13M -3.12% | -42.347M -56.09% | -55.999M -32.24% | -21.937M 60.83% | -6.693M 69.49% | 1.654M 124.71% | 117.38M 6,996.74% | 155.07M 32.11% | 241.26M 55.58% | 320.71M 32.93% | 410.97M 28.14% | |
| Operating Margin | -78.82% | -84.45% | -87.16% | -26.62% | -6.01% | 0.99% | 41.34% | 43.94% | 59.86% | 67.19% | 70.70% | |
| EPS YoY % growth | -1.07 8.55% | -1.40 -30.84% | -2.39 -70.71% | -0.81 65.99% | -0.31 61.33% | 0.08 124.34% | 4.40 5,655.33% | 5.65 28.24% | 6.93 22.75% | 8.80 26.91% | 11.36 29.20% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.18 70.80% | -0.10 76.82% | -0.21 59.58% | -0.08 78.53% | 0.04 122.54% | 0.02 120.00% | 0.00 -100.00% |
| Revenue Q2Q % growth | 22.472M 14.97% | 24.284M 31.94% | 24.48M 32.22% | 25.245M 37.07% | 28.203M 25.50% | 28.968M 19.29% | 32.895M 13.56% |
| EBITDA Q2Q % growth | -5.508M 57.36% | -5.457M 38.37% | -6.63M 39.69% | -2.04M -100.93% | 1.938M 135.19% | 1.326M 124.30% | 7.752M 484.62% |
| EBIT Q2Q % growth | -4.264M 68.73% | -2.876M 71.18% | -6.477M 43.75% | -3.876M -101.77% | -612K 85.65% | -51K 98.23% | 1.836M 3,700.00% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.38 36.67% | -0.25 | -0.13 | -50.22% |
| Q1 2025 Q2Q % growth | -0.53 27.40% | -0.39 | -0.14 | -34.96% |
| Q4 2024 Q2Q % growth | -0.44 -57.14% | -0.44 | 0.00 | 0.41% |
| Q3 2024 Q2Q % growth | -0.62 -82.35% | -0.45 | -0.17 | -39.31% |
| Q2 2024 Q2Q % growth | -0.60 -46.34% | -0.53 | -0.07 | -13.56% |
| Q1 2024 Q2Q % growth | -0.73 -97.30% | -0.48 | -0.25 | -51.24% |
| Q4 2023 Q2Q % growth | -0.28 -27.27% | -0.38 | 0.10 | 26.68% |
| Q3 2023 Q2Q % growth | -0.34 -54.55% | -0.45 | 0.11 | 24.92% |
| Q2 2023 Q2Q % growth | -0.41 -64.00% | -0.33 | -0.08 | -23.91% |
| Q1 2023 Q2Q % growth | -0.37 2.63% | -0.26 | -0.11 | -44.52% |
| Q4 2022 Q2Q % growth | -0.22 -29.41% | -0.30 | 0.08 | 26.20% |
| Q3 2022 Q2Q % growth | -0.22 15.38% | -0.35 | 0.13 | 36.47% |
| Q2 2022 Q2Q % growth | -0.25 3.85% | -0.40 | 0.15 | 37.15% |
| Q1 2022 Q2Q % growth | -0.38 20.83% | -0.39 | 0.01 | 1.96% |
| Q4 2021 Q2Q % growth | -0.17 71.67% | -0.40 | 0.23 | 57.54% |
| Q3 2021 Q2Q % growth | -0.26 63.38% | -0.39 | 0.13 | 32.92% |
| Q2 2021 Q2Q % growth | -0.26 56.67% | -0.29 | 0.03 | 11.34% |
| Q1 2021 Q2Q % growth | -0.48 32.39% | -0.31 | -0.17 | -55.57% |
| Q4 2020 Q2Q % growth | -0.60 | -0.44 | -0.16 | -35.23% |
| Q3 2020 Q2Q % growth | -0.71 | -0.39 | -0.32 | -82.82% |
| Q2 2020 Q2Q % growth | -0.60 | -0.25 | -0.35 | -140.10% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 18.418M 21.21% | 23.061M | -4.643M | -20.13% |
| Q1 2025 Q2Q % growth | 18.514M 66.73% | 21.565M | -3.051M | -14.15% |
| Q4 2024 Q2Q % growth | 18.406M 29.67% | 21.464M | -3.058M | -14.25% |
| Q3 2024 Q2Q % growth | 19.546M 43.25% | 19.814M | -268K | -1.35% |
| Q2 2024 Q2Q % growth | 15.195M 29.29% | 15.028M | 167K | 1.11% |
| Q1 2024 Q2Q % growth | 11.104M 5.25% | 11.268M | -164K | -1.46% |
| Q4 2023 Q2Q % growth | 14.195M 50.05% | 14.79M | -595K | -4.02% |
| Q3 2023 Q2Q % growth | 13.645M 50.11% | 13.635M | 10K | 0.07% |
| Q2 2023 Q2Q % growth | 11.753M 40.92% | 11.547M | 206K | 1.78% |
| Q1 2023 Q2Q % growth | 10.55M 39.92% | 10.538M | 12K | 0.11% |
| Q4 2022 Q2Q % growth | 9.46M 36.31% | 8.849M | 611K | 6.90% |
| Q3 2022 Q2Q % growth | 9.09M 29.49% | 7.173M | 1.917M | 26.73% |
| Q2 2022 Q2Q % growth | 8.34M -19.03% | 7.293M | 1.047M | 14.36% |
| Q1 2022 Q2Q % growth | 7.54M -14.03% | 6.913M | 627K | 9.07% |
| Q4 2021 Q2Q % growth | 6.94M 36.08% | 7.14M | -200K | -2.80% |
| Q3 2021 Q2Q % growth | 7.02M 38.74% | 6.881M | 139.335K | 2.03% |
| Q2 2021 Q2Q % growth | 10.3M 52.01% | 8.043M | 2.257M | 28.06% |
| Q1 2021 Q2Q % growth | 8.77M 76.74% | 6.883M | 1.887M | 27.42% |
| Q4 2020 Q2Q % growth | 5.1M | 5.712M | -612K | -10.71% |
| Q3 2020 Q2Q % growth | 5.06M | 4.998M | 62K | 1.24% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -39.22% | -21.58% | -16.55% | -19.52% |
| Revenue | -16.16% | -19.07% | -18.41% | -19.6% |